Skip to main navigation
Skip to search
Skip to main content
Sort by
INIS
tissues
100%
regeneration
80%
myocardial infarction
77%
delivery
56%
drug delivery
34%
therapy
32%
inflammation
32%
cardiovascular diseases
31%
stem cells
25%
repair
24%
reviews
21%
drugs
20%
healing
20%
macrophages
19%
fibrosis
18%
stimuli
18%
wounds
18%
research programs
16%
peptides
15%
polarization
15%
gene therapy
15%
polymers
15%
immunology
15%
biological materials
15%
growth factors
14%
applications
10%
diseases
10%
animals
10%
mortality
9%
death
8%
heart failure
8%
patients
8%
genes
8%
angiogenesis
8%
biological availability
7%
cost
7%
humans
7%
matrices
7%
skin
6%
migration
6%
risks
6%
metabolism
6%
clinical trials
6%
nose
6%
fibroblasts
5%
toxicity
5%
cytokines
5%
injuries
5%
phenotype
5%
Keyphrases
Myocardial Infarction
46%
Cardiac Regeneration
46%
Heart Function
30%
Targeted Delivery
30%
Tissue Regeneration
23%
Cardiovascular Disease
21%
Collaborative Research
17%
Chitosan
17%
Controlled Release
15%
Recent Advances
15%
Biomaterials
15%
Mucosal Drug Delivery
15%
Ocular Drug Delivery
15%
Stimuli-responsive Polymers
15%
Oromucosal
15%
Transdermal Drug Delivery
15%
Mesenchymal Stem Cells
15%
Macrophage Polarization
15%
Immunomodulatory Potential
15%
Inflammation
10%
Mesenchymal Stem
10%
Cell-based
10%
Macrophages
9%
Kazakhstan
7%
Immune System
7%
Diffusion Kinetics
7%
Drug Administration Routes
7%
Mucosa
7%
Diffusion Parameters
7%
Intravenous Route
7%
Gastrointestinal Tract
7%
Drug Formulation
7%
Enzymatic Degradation
7%
Primary Metabolism
7%
First-pass Metabolism
7%
Transdermal Route
7%
Nasal Route
7%
Stimuli-responsive Materials
7%
Storage Safety
7%
Ocular Route
7%
Storage Stability
7%
Orally Administered
7%
Oral Route
7%
Release Kinetics
7%
Drug Delivery
7%
Tissue Damage
7%
Nasal
7%
Permeation Rate
7%
Infection Risk
7%
Adverse Reactions
7%
Intravenous Infusion
7%
Multiple Drugs
7%
Transdermal
7%
Liver
7%
Activated Macrophages
6%
Fibrosis
5%
Causes of Mortality
5%
Sustained Release
5%
Stem Cell Therapy
5%
Stem Cells
5%
Wound Healing
5%
Informal Care Costs
5%
Angiogenesis
5%
Quality of Life
5%
Oxidative Stress
5%
Immunomodulatory
5%
Coronary Artery Disease
5%
Productivity Loss
5%
Healing Factor
5%
Inconsistency
5%
Clinical Application
5%
Therapeutic Potential
5%
Clinical Outcomes
5%
Therapeutic Goals
5%
Clinical Trials
5%
Cellular Products
5%
Migration Capacity
5%
Therapeutic Effect
5%
Immunomodulatory Properties
5%
Survival Rate
5%
Homing Capacity
5%
Donor-derived
5%
Immunosuppressive Properties
5%
Inflammatory System
5%
Medicine and Dentistry
Tissue Regeneration
49%
Myocardial Infarction
30%
Heart Function
30%
Cardiovascular Disease
27%
Mesenchymal Stem Cell
15%
Gene Therapy
15%
Stem Cell Therapy
10%
Health Care Cost
9%
Disease
9%
Angiogenesis
6%
Clinical Trial
6%
Controlled Release
5%
Stem Cell
5%
Clinician
5%
Growth Factor
5%